News

The initial results are expected by the second week of May, 2008. These animal studies will be conducted by Krishna Menon, a world-renowned authority in preclinical and toxicological

The Phase II clinical trial is a randomized, controlled clinical study in soft tissue to evaluate the superiority of the Fibrin Patch compared to Surgicel. The primary endpoint

It is anticipated that Pradaxa will be launched in Germany and the UK in the coming weeks. Pradaxa is approved for the prevention of venous thromboembolic events in

Preliminary evaluation of biological samples collected from the study’s first and second cohorts indicated that administration of HspE7 results in an E7-specific T-cell immune response. Nventa believes that

The intention with the new Phase IIb dose ranging study is to expand the clinical and commercial potential for eprotirome in dyslipidemia treatment by exploring whether eprotirome in

The agreement sets the terms under which Novation members can acquire Olympus AU series analyzers, automation systems, reagents, consumables, parts, service and technical support. The contract spans three

Under the agreement, Ono will pay to Evotec initial payments (technology access fee) for access to Evotec’s fragment-based drug discovery platform, EVOlution, research funding as well as success-based

Quintiles will have its own staff at the College of American Pathologists-certified Medca Japan laboratory in Saitama, a city in the Greater Tokyo area. The lab will support

The company expects to begin commercial sales of the Endeavor stent in Canada by the end of March, 2008. Medtronic will also provide annual updates on its Endeavor